MGD is an ocular surface disease that is caused by obstruction of the terminal ducts of the lid gland and/or abnormal secretions of the lid gland, resulting in a series of symptoms such as decreased stability of the tear film and ocular discomfort. the onset of MGD is age and race related, with a prevalence of 46.2%-69.3% in Asian populations over 60 years of age. the diagnosis and treatment of this disease is currently the focus of research in the field of ophthalmology in China and The diagnosis and treatment of this disease is currently the focus of research in the field of ophthalmology in China. According to a survey published by Google in 2013, as many as 81% of people must take their cell phones with them when they go out, and the dependence on cell phones is increasing. Long-term use of mobile phones not only affects vision, but also reduces the number of blinks by staring at the screen for long periods of time, which prevents the tear film from being distributed evenly across the eye with the blinking motion, causing oil to accumulate in the lid glands and prevent discharge. If left untreated, this can lead to more serious eye diseases such as corneal inflammation. In addition to overuse of the eyes and long-term use of electronic devices, some patients with autoimmune diseases, post-operative facial plastic surgery and cosmetic surgery, Botox injections, and inadequate eye makeup cleaning are also at high risk for dry eye disease. Regarding the examination and treatment of MGD, Prof. Bi Hong-sheng said that in the past, only basic tear secretion was checked and then eye drops or ointments were given to relieve dry eye symptoms, but there was no effective examination for patients suffering from MGD, resulting in less effective treatment. The LipiFlow system is an effective treatment for MGD that has been popularized in the United States and Europe in recent years. It uses pulsed pressure between the eye cup and the eyelid heater to apply intermittent pressure to the eyelid, while using a special heating system of the eyelid heater to treat the lid gland. The safety of the Heat Pulsation System (LipiFlow) was previously validated by FDA clinical trials in the U.S. This fills a gap in the treatment of dry eye due to lid gland dysfunction. Diagnostic Process: The frequency and severity of dry eye is assessed using the SPEED questionnaire to confirm the presence or absence of dry eye, the thickness of the tear film is tested to assess health, and the amount of oil produced by the lid gland is directly observed. Treatment steps: The lid gland opening is first cleared to allow for smooth flow of oil, which helps to sustain the results of the treatment. The lid gland is then heated at a constant temperature of 42.5 degrees on the inside of the eyelid using a lid thermal pulsation therapy device to soften the clotted oil. After treatment, it is important to avoid overuse of the eyes and to rest them regularly to ensure that the treatment lasts and that you have a brighter life!